Investigation of Contraception Given to Ethiopian Women To Be Launched
Image by haaretz
State Comptroller Yosef Shapira announced on Sunday he would launch a probe into the allegations that Ethiopian women who sought to immigrate to Israel were administered the long-acting contraceptive Depo-Provera with the intent of reducing birthrate within Ethiopian community.
The comptroller’s announcement said that “it is possible that some of the women did not understand” what was at stake when they received the shots. The comptroller went on to explain that the decision to examine the use of Depo-Provera came in response to “appeals by female Knesset members, headed by chairman of the Knesset Committee on the Rights of the Child Orly Levi-Abekasis.”
A special division within the comptroller’s office will lead the investigation, and an additional commission will be established to look into the practice if needed.
Levi-Abekasis and several other Knesset members turned to the comptroller following a report by the Knesset Research and Information Center regarding widespread use of the injections in the transit camps in Ethiopia. The report revealed that a vast majority of women who took part in family planning workshops in the camps received the contraceptive shots. The study by the Knesset research institute presents worrying data about the conduct of the state in the transit camps.
Read more at Haaretz.com.
A message from our CEO & publisher Rachel Fishman Feddersen
I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.
At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and polarized discourse.
Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.
— Rachel Fishman Feddersen, Publisher and CEO
